A field guide to BPC-157The criteria
PRODUCT / CARE / COMMITMENT
Open the provider file

Research explained

Finding BPC-157 metabolites with isotope labeling

An assay can detect exposure without establishing efficacy, product quality or a safe regimen.

On this page

Read the experiment

The finding and its boundary

The investigators identified metabolites and validated a sensitive method to detect parent peptide and selected metabolites. An assay can detect exposure without establishing efficacy, product quality or a safe regimen.

Stable Isotope Labeling-Based Nontargeted Strategy for Characterization of the In Vitro Metabolic Profile of a Novel Doping BPC-157 in Doping Control by UHPLC-HRMS.

Experiment
Laboratory materials or analytical-method investigation.
Study system
In-vitro incubation models and a validated human-urine analytical method
Measured outcome
Metabolite identification and assay performance
Reported result
The investigators identified metabolites and validated a sensitive method to detect parent peptide and selected metabolites.
What this cannot establish
An assay can detect exposure without establishing efficacy, product quality or a safe regimen.
Open the primary paper

What was actually tested

In-vitro incubation models and a validated human-urine analytical method. The investigators measured metabolite identification and assay performance. The investigators identified metabolites and validated a sensitive method to detect parent peptide and selected metabolites.

The detail that changes the takeaway

A metabolite is useful to anti-doping analysis because it may leave a detectable signature. That purpose differs from deciding whether a product works. Detection limits belong to the instrument method; they are not a threshold below which a treatment is clinically safe.

How far the result travels

An assay can detect exposure without establishing efficacy, product quality or a safe regimen.

A useful comparison

BPC-157 identification in confiscated material examines peptide identity, metabolites and assay performance. Here, the measured endpoint was metabolite identification and assay performance. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the Can one BPC-157 study support the product in front of you? appraisal.

References & product documents

The evidence and service information used here.

  1. Finding BPC-157 metabolites with isotope labeling — original indexed research

Next in the field guide

The provider file
  1. 01

    BPC-157 identification in confiscated material

    Identification in a tested sample is not validation of every seller, batch or medical product.

  2. 02

    Can one BPC-157 study support the product in front of you?

    Match the claim, ingredient, route and outcome. A relevant paper can still leave the central purchasing question unanswered.

  3. 03

    BPC-157 and a corneal incision: closure in rats is not restored human vision

    The 2015 experiment measured a surgically created eye injury. It does not establish a safe ophthalmic product or a personal treatment option.

Before you leave

One more option to compare.

Another provider review

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

Continue to your choiceRead another review